
Topical Scar Treatment Market - Global Outlook & Forecast 2022-2027
Description
Topical Scar Treatment Market - Global Outlook & Forecast 2022-2027
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Topical Scar Treatment Market Report
The topical scar treatment market by revenue is expected to grow at a CAGR of 4.58% during the period 2022–2027.
MARKET INSIGHTS
In topical scar treatment, Keloid scars are more common in Asian, African, and UK countries that highly demand the treatments. The increasing number of burn injuries in those regions drives the market growth. Burn injuries are the major factor that causes scar contracture, which drives the demand for scar treatments. Topical scar treatment products such as gel and silicone scar sheets are the best product solutions that reduce scar appearance. Changing the preference of people from offline to online shopping has positively impacted the sale of topical scar treatment products by the e-commerce platform, thereby boosting the market growth.
The following factors are likely to contribute to the growth of the topical scar treatment market.
TOPICAL SCAR TREATMENT MARKET SEGMENTATION
This research report includes a detailed segmentation by:
1. How big is the topical scar treatment market?
2. Which region holds the highest share in the topical scar treatment market?
3. Who are the key players in the topical scar treatment market?
4. What are the major factors driving the growth of the topical scar treatment market?
5. What are the key trends in the topical scar treatment market?
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Topical Scar Treatment Market Report
The topical scar treatment market by revenue is expected to grow at a CAGR of 4.58% during the period 2022–2027.
MARKET INSIGHTS
In topical scar treatment, Keloid scars are more common in Asian, African, and UK countries that highly demand the treatments. The increasing number of burn injuries in those regions drives the market growth. Burn injuries are the major factor that causes scar contracture, which drives the demand for scar treatments. Topical scar treatment products such as gel and silicone scar sheets are the best product solutions that reduce scar appearance. Changing the preference of people from offline to online shopping has positively impacted the sale of topical scar treatment products by the e-commerce platform, thereby boosting the market growth.
The following factors are likely to contribute to the growth of the topical scar treatment market.
- Changing concern about better face/ skin appearance
- Increasing cases of keloids scars & scars appearance induced injuries
- Increasing the use of OTC scar treatment products for home use
- Increasing Prevalence of Burn Injuries and Rising Demand for Burn Scar Treatments
- High demand for Acne Scar Removal by Teenager & Adult Age Group
- Increasing Number of Surgical Procedures & Accidental Cases
- High Demand for Silicone-Based Products for Scar’s Treatments
TOPICAL SCAR TREATMENT MARKET SEGMENTATION
This research report includes a detailed segmentation by:
- Scar Type
- Form
- Distribution Channels
- Geography
- The acne scar type segment accounted for around 34% of the market share in the global topical scar treatment market and with a growth rate of around 5% CAGR during the forecast period. The high prevalence of acne in adults and teens leaves a scar appearance, which influences the demand for topical scar treatment products in the market.
- The increasing adult and teenage population and rising pollution induced acne's appearance on the human face, leading to the atrophic scar’s appearance. Thereby, the increasing prevalence of raised scars derives the demand for acne scars topical treatment products in the market.
- Keloids Scars and Hypertrophic Scars
- Acne Scars
- Contracture Scars
- Gel
- Scar Sheets
- Others
- Hospital and Retail Pharmacies
- Online Sales Channel
- Other Distribution Channels
- Supermarket and Hypermarket
- Wellness Centers
- North America is one of the leading countries by economy and healthcare concern that drives the application of rate of topical scar treatment products. On the other hand, several manufacturers are available in the region, which will boost the market growth.
- According to Global Times, around 15 million licensed procedures of plastic surgeries were done in China in 2017 and approximately 20 million in 2018. The increasing number of cosmetic surgeries leave a scar appearance. Even the smaller scar appearance on facial surfaces drives the demand for scar reduction treatments to better the market growth.
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- APAC
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa
- Turkey
- South Africa
- Saudi Arabia
- Perrigo acquired two scar treatment product manufacturers such as Tracxn and HRA Pharma. HRA pharma brand product Mederma is one of the leading products in the topical scar treatment market, and it is highly suggested by dermatologists. Mederma is one of the high-sale products for scar treatment in the international market.
- Perrigo Company Plc
- HRA Pharma
- Molnlycke Healthcare AB
- Newmedical Technology
- Alliance Pharma
- Smith+Nephew
- Aroamas LLC
- Biodermis
- Implus (Spenco)
- Genomma Lab Internacional
- Revitol Corporation
- Eucare Pharmaceuticals
- Galderma
- Integra LifeSciences
- Johnson & Johnson
- Loreal
- Mylan N.V.
- Murud Inc
- Oculus Innovative Sciences Inc.
- Pharmaxis Ltd
- Rejuvaskin
- Re’equil
- Sientra
- SkinKraft
- The Menarini Group
- Terez & Honor
- Promore Pharma
1. How big is the topical scar treatment market?
2. Which region holds the highest share in the topical scar treatment market?
3. Who are the key players in the topical scar treatment market?
4. What are the major factors driving the growth of the topical scar treatment market?
5. What are the key trends in the topical scar treatment market?
Table of Contents
249 Pages
- 1 Research Methodology
- 2 Research Objectives
- 3 Research Process
- 4 Scope & Coverage
- 4.1 Market Definition
- 4.1.1 Inclusions
- 4.1.2 Exclusions
- 4.1.3 Market Estimation Caveats
- 4.2 Base Year
- 4.3 Scope of The Study
- 4.3.1 Market Segmentation by Types of Scars
- 4.3.2 Market by Form
- 4.3.3 Market by Distribution Channels
- 4.3.4 Market Segmentation by Geography
- 5 Report Assumptions & Caveats
- 5.1 Key Caveats
- 5.2 Currency Conversion
- 5.3 Market Derivation
- 6 Market at a Glance
- 7 Introduction
- 7.1 Overview
- 8 Market Opportunities & Trends
- 8.1 Growing Concern Toward Face / Skin Appearance
- 8.2 Rising Cases of Keloid Scars
- 8.3 Increasing Use of OTC Scar Treatment Products at Home
- 9 Market Growth Enablers
- 9.1 Rising Demand for Burn Scar Treatment
- 9.2 High Demand for Acne Scar Removal Products Among Teenagers & Adults
- 9.3 Increase in Surgeries & Accidents
- 9.4 High Demand for Silicone-Based Products
- 10 Market Growth Restraints
- 10.1 Alternative Options for Topical Scar Treatment
- 10.2 Potential Allergic Reactions
- 11 Market Landscape
- 11.1 Market Overview
- 11.2 Market Size & Forecast
- 11.2.1 Market by Geography
- 11.2.2 Market by Scar Type
- 11.2.3 Market by Form
- 11.2.4 Market by Distribution Channel
- 11.3 Five Forces Analysis
- 11.3.1 Threat of New Entrants
- 11.3.2 Bargaining Power of Suppliers
- 11.3.3 Bargaining Power of Buyers
- 11.3.4 Threat of Substitutes
- 11.3.5 Competitive Rivalry
- 12 Scar Type
- 12.1 Market Snapshot & Growth Engine
- 12.2 Market Overview
- 12.3 Keloid & Hypertrophic Scars
- 12.3.1 Market Overview
- 12.3.1 Market Size & Forecast
- 12.3.2 Market by Geography
- 12.4 Acne Scars
- 12.4.1 Market Overview
- 12.4.2 Market Size & Forecast
- 12.4.3 Market by Geography
- 12.5 Contracture Scars
- 12.5.1 Market Overview
- 12.5.2 Market Size & Forecast
- 12.5.3 Market by Geography
- 13 Form
- 13.1 Market Snapshot & Growth Engine
- 13.2 Market Overview
- 13.3 Gel
- 13.3.1 Market Overview
- 13.3.2 Market Size & Forecast
- 13.3.3 Market by Geography
- 13.4 Scar Sheets
- 13.4.1 Market Overview
- 13.4.2 Market Size & Forecast
- 13.4.3 Market by Geography
- 13.5 Others
- 13.5.1 Market Overview
- 13.5.2 Market Size & Forecast
- 13.5.3 Market by Geography
- 14 Distribution Channel
- 14.1 Market Snapshot & Growth Engine
- 14.2 Market Overview
- 14.3 Hospital & Retail Pharmacies
- 14.3.1 Market Overview
- 14.3.2 Market Size & Forecast
- 14.3.3 Market by Geography
- 14.4 Online
- 14.4.1 Market Overview
- 14.4.2 Market Size & Forecast
- 14.4.3 Market by Geography
- 14.5 Others
- 14.5.1 Market Overview
- 14.5.2 Market Size & Forecast
- 14.5.3 Market by Geography
- 15 Geography
- 15.1 Market Snapshot & Growth Engine
- 15.2 Geographic Overview
- 16 North America
- 16.1 Market Overview
- 16.2 Market Size & Forecast
- 16.3 Scar Type
- 16.4 Form
- 16.5 Distribution Channel
- 16.6 Key Countries
- 16.6.1 US: Market Size & Forecast
- 16.6.2 Canada: Market Size & Forecast
- 17 Europe
- 17.1 Market Overview
- 17.2 Market Size & Forecast
- 17.3 Scar Type
- 17.4 Form
- 17.5 Distribution Channel
- 17.6 Key Countries
- 17.6.1 Germany: Market Size & Forecast
- 17.6.2 France: Market Size & Forecast
- 17.6.3 UK: Market Size & Forecast
- 17.6.4 Italy: Market Size & Forecast
- 17.6.5 Spain: Market Size & Forecast
- 18 APAC
- 18.1 Market Overview
- 18.2 Market Size & Forecast
- 18.3 Scar Type
- 18.4 Form
- 18.5 Distribution Channel
- 18.6 Key Countries
- 18.6.1 Japan: Market Size & Forecast
- 18.6.2 China: Market Size & Forecast
- 18.6.3 India: Market Size & Forecast
- 18.6.4 Australia: Market Size & Forecast
- 18.6.5 South Korea: Market Size & Forecast
- 19 Latin America
- 19.1 Market Overview
- 19.2 Market Size & Forecast
- 19.3 Scar Type
- 19.4 Form
- 19.5 Distribution Channel
- 19.6 Key Countries
- 19.6.1 Brazil: Market Size & Forecast
- 19.6.2 Mexico: Market Size & Forecast
- 19.6.3 Argentina: Market Size & Forecast
- 20 Middle East & Africa
- 20.1 Market Overview
- 20.2 Market Size & Forecast
- 20.3 Scar Type
- 20.4 Form
- 20.5 Distribution Channel
- 20.6 Key Countries
- 20.6.1 Turkey: Market Size & Forecast
- 20.6.2 South Africa: Market Size & Forecast
- 20.6.3 Saudi Arabia: Market Size & Forecast
- 21 Competitive Landscape
- 21.1 Competition Overview
- 21.2 Market Share Analysis
- 21.2.1 Perrigo Company Plc
- 21.2.2 HRA Pharma
- 21.2.3 MOLNLYCKE Health Care Ab
- 21.2.4 Alliance Pharma
- 21.2.5 New medical Technology
- 22 Key Company Profiles
- 22.1 PERRIGO COMPANY PLC
- 22.1.1 Business Overview
- 22.1.2 Product Offering
- 22.1.3 Key Strategies
- 22.1.4 Key Strengths
- 22.1.5 Key Opportunities
- 22.2 HRA PHARMA
- 22.2.1 Business Overview
- 22.2.2 Key Strategies
- 22.2.3 Key Strengths
- 22.2.4 Key Opportunities
- 22.3 MOLNLYCKE HEALTH CARE AB
- 22.3.1 Business Overview
- 22.3.2 Product Offerings
- 22.3.3 Key Strategies
- 22.3.4 Key Strength
- 22.3.5 Key Opportunities
- 22.4 NEWMEDICAL TECHNOLOGY
- 22.4.1 Business Overview
- 22.4.2 Product Offering
- 22.4.3 Key Strategies
- 22.4.4 Key Strength
- 22.4.5 Key Opportunities
- 22.5 ALLIANCE PHARMA
- 22.5.1 Business Overview
- 22.5.2 Product Offerings
- 22.5.3 Key Strategies
- 22.5.4 Key Strength
- 22.5.5 Key Opportunities:
- 22.6 SMITH+NEPHEW
- 22.6.1 Business Overview
- 22.6.2 Product Offerings
- 22.6.3 Key Strategies
- 22.6.4 Key Strengths
- 22.6.5 Key Opportunities
- 23 Other Prominent Vendors
- 23.1 AROAMAS LLC
- 23.1.1 Business Overview
- 23.1.2 Product Offerings
- 23.2 BIODERMIS
- 23.2.1 Business Overview
- 23.2.2 Product Offerings
- 23.3 IMPLUS (SPENCO)
- 23.3.1 Business Overview
- 23.3.2 Product Offerings
- 23.4 GENOMMA LAB INTERNACIONAL
- 23.4.1 Business Overview
- 23.4.2 Product Offerings
- 23.5 REVITOL CORPORATION
- 23.5.1 Business Overview
- 23.5.2 Product Offerings
- 23.6 EUCARE PHARMACEUTICALS
- 23.6.1 Business Overview
- 23.6.2 Product Offering
- 23.7 GALDERMA
- 23.7.1 Business Overview
- 23.7.2 Products Offering
- 23.8 INTEGRA LIFESCIENCES
- 23.8.1 Business Overview:
- 23.8.2 Product Offerings
- 23.9 JOHNSON & JOHNSON
- 23.9.1 Business Overview
- 23.9.2 Product Offerings
- 23.10 LOREAL
- 23.10.1 Business Overview
- 23.10.2 Product Offering
- 23.11 MYLAN N.V.
- 23.11.1 Business Overview
- 23.11.2 Product Offerings
- 23.12 MURUD INC
- 23.12.1 Business Overview
- 23.12.2 Products Offering
- 23.13 OCULUS INNOVATIVE SCIENCES INC.
- 23.13.1 Business Overview
- 23.13.2 Product Offerings
- 23.14 PHARMAXIS
- 23.14.1 Business Overview
- 23.14.2 Products Offering
- 23.15 REJUVASKIN
- 23.15.1 Business Overview
- 23.15.2 Products Offering
- 23.16 RE’EQUIL
- 23.16.1 Business Overview
- 23.16.2 Products Offering
- 23.17 SIENTRA
- 23.17.1 Business Overview
- 23.17.2 Product Offerings
- 23.18 SKINKRAFT
- 23.18.1 Business Overview
- 23.18.2 Products Offering
- 23.19 MENARINI GROUP
- 23.19.1 Business Overview
- 23.20 TEREZ &HONOR
- 23.20.1 Business Overview
- 23.20.2 Product Offerings
- 23.21 PROMORE PHARMA
- 23.21.1 Business Overview
- 23.21.2 Product Offering
- 24 Report Summary
- 24.1 Key Takeaways
- 24.2 Strategic Recommendations
- 25 Quantitative Summary
- 25.1 Market by Geography
- 25.2 Market by Type
- 25.2.1 North America
- 25.2.2 Europe
- 25.2.3 APAC
- 25.2.4 Latin America
- 25.2.5 Middle East & Africa
- 25.3 Market by Form
- 25.3.1 North America
- 25.3.2 Europe
- 25.3.3 APAC
- 25.3.4 Latin America
- 25.3.5 Middle East Africa
- 25.4 Market by Distribution Channel
- 25.4.1 North America
- 25.4.2 Europe
- 25.4.3 APAC
- 25.4.4 Latin America
- 25.4.5 Middle East & Africa
- 26 Appendix
- 26.1 Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.